A company operating in the pharmaceutical sector, Biocon’s shares have been witnessing steady growth between 5th and 10th May 2023. The Serum Institute of Life Sciences will invest 300 million dollar in Biocon Biologicals, cementing the company’s prospects. Thus, the future of Biocon looks promising.
The factors affecting the stock price of Biocon are as follows –
Over the long-term horizon, Biocon is expected to grow its business. Since the company has domestic and international demand and the pharma sector is booming, you might benefit from investing in Biocon over the long run. Moreover, with a long-term horizon, you can avoid short-term volatility risks of the market and get capital appreciation on your investment.
As per the financial results of the financial year 2022-23, the company has declared a final dividend of 10% of the face value of each share. This converts to a dividend of 0.50.
The frequency of dividend payments depends on the profitability of the company. Over the past few years, here’s when the company has paid a dividend –